Initiation and persistence with warfarin therapy in atrial fibrillation according to ethnicity

3Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

Abstract

The aim of this study was to investigate initiation of and persistence with warfarin treatment in patients with atrial fibrillation (AF) according to ethnicity. Patients hospitalized with first-time AF from 1997 to 2009, prescription claims of warfarin and country of birth were identified by individual-level linkage of nationwide administrative agencies. Cox proportional hazards models were used to estimate the relationship between covariates affecting initiation and non-persistence with warfarin treatment. A total of 151,537 patientswere included in the study and 5,061(3.3%) were of non-Danish origin. CHADS2 score distribution varied substantially according to ethnicity, the proportion of patients with CHADS2 score ≥1 being 79.2, 78.1, 65.9, and 46.0% for patients of Danish,Western, Eastern, and African origin, respectively. 79,239(52.4%) of all patients initiated treatment with warfarin at some point in time. Multivariable Cox proportional hazard analyses indicated patients of Eastern and African origin were less likely to initiate warfarin therapy (HR 0.75; 95% CI 0.69-0.82 and HR 0.58; 95% CI 0.44-0.76, respectively). Patients of Eastern origin were more likely to interrupt treatmets with CHADS2 score >1). African origin was associated with a trend to interrupnt (HR 1.23; 95% CI 1.02-1.47; for all patients; HR 1.62; 95% CI 1.22-2.16; for patient treatment (HR 1.44; 95% CI 0.46-4.47; for patients with CHADS2 score >1). Initiation of and persistence withwarfarin in AF patients is lower among patients of Eastern and African origin compared to patients of Danish andWestern origin, despite equal access to health care and medication. Future studies should address, beyond ethnicity, all possible driving factors of (non)initiation and persistence with treatment in general.This will be particularly interesting in light of the new generation of anticoagulants, which might render different adherence to treatment. © 2012 Hansen, Olesen, Hansen, Azimi, Torp-Pedersenand Dominguez.

Cite

CITATION STYLE

APA

Hansen, C. M., Olesen, J. B., Hansen, M. L., Azimi, A., Torp-Pedersen, C., & Dominguez, H. (2012). Initiation and persistence with warfarin therapy in atrial fibrillation according to ethnicity. Frontiers in Pharmacology, 3 JUN, 1–8. https://doi.org/10.3389/fphar.2012.00123

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free